NCT01382199View on ClinicalTrials.gov

Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients

PHASE3UnknownINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

March 31, 2014

Conditions
Diarrhea
Interventions
DRUG

Lactoferrin

Sponsors

Lead Sponsor

Ventria Bioscience
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Ventria Bioscience

INDUSTRY

NCT01382199 - Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients | Biotech Hunter | Biotech Hunter